{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:19:24Z","timestamp":1780852764295,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100386"],"award-info":[{"award-number":["81100386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400046"],"award-info":[{"award-number":["81400046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100386"],"award-info":[{"award-number":["81100386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400046"],"award-info":[{"award-number":["81400046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.intimp.2018.08.030","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T23:01:32Z","timestamp":1536274892000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-3729","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.intimp.2018.08.030_bb0005","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","article-title":"Reversal of global CD4(+) subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis","volume":"190","author":"Oswald-Richter","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2018.08.030_bb0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/1744666X.2016.1181541","article-title":"Advances in understanding the immunopathology of sarcoidosis and implications on therapy","volume":"12","author":"Cinetto","year":"2016","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2018.08.030_bb0015","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.intimp.2018.08.030_bb0020","doi-asserted-by":"crossref","first-page":"17515","DOI":"10.1074\/jbc.M113.545871","article-title":"Caerulomycin A enhances transforming growth factor-beta (TGF-beta)-Smad3 protein signaling by suppressing interferon-gamma (IFN-gamma)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs)","volume":"289","author":"Gurram","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2018.08.030_bb0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/thorax.56.6.487","article-title":"Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis","volume":"56","author":"Mollers","year":"2001","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J. Exp. Med."},{"issue":"9923","key":"10.1016\/j.intimp.2018.08.030_bb0035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2353\/ajpath.2009.080580","article-title":"FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions","volume":"174","author":"Taflin","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.030_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clim.2011.03.015","article-title":"Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation","volume":"140","author":"Rappl","year":"2011","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2018.08.030_bb0050","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2(+) regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2018.08.030_bb0055","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/cea.13027","article-title":"IL-33 and IgE stimulate mast cell production of IL-2 and regulatory T cell expansion in allergic dermatitis","volume":"47","author":"Salamon","year":"2017","journal-title":"Clin. Exp. Allergy"},{"issue":"43","key":"10.1016\/j.intimp.2018.08.030_bb0060","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.030_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ni.3085","article-title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2018.08.030_bb0070","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.1100519","article-title":"IL-33 expands suppressive CD11b(+) gr-1(int) and regulatory T cells, including ST2L(+) Foxp3(+) cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival","volume":"187","author":"Turnquist","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.030_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2119\/molmed.2011.00428","article-title":"Interleukin-33 ameliorates experimental colitis through promoting Th2\/Foxp3(+) regulatory T-cell responses in mice","volume":"18","author":"Duan","year":"2012","journal-title":"Mol. Med."},{"issue":"7519","key":"10.1016\/j.intimp.2018.08.030_bb0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1165\/rcmb.2009-0350OC","article-title":"Development of a sarcoidosis murine lung granuloma model using mycobacterium superoxide dismutase a peptide","volume":"44","author":"Swaisgood","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.3077","article-title":"Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability","volume":"16","author":"Huynh","year":"2015","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2018.08.030_bb0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3(+) regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.030_bb0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.intimp.2018.08.030_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/ker316","article-title":"Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis","volume":"51","author":"ten Berge","year":"2012","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2018.08.030_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-015-0265-8","article-title":"Impaired survival of regulatory T cells in pulmonary sarcoidosis","volume":"16","author":"Broos","year":"2015","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.intimp.2018.08.030_bb0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.200909-1451OC","article-title":"Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in Sarcoidosis","volume":"182","author":"Prasse","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2018.08.030_bb0125","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Prefontaine","year":"2009","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2018.08.030_bb0130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based Genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2018.08.030_bb0135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ng.888","article-title":"Meta-analysis of genome-wide association studies of asthma in ethnically diverse north American populations","volume":"43","author":"Torgerson","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.030_bb0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis - a clinical evaluation","volume":"124","author":"Grutters","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.intimp.2018.08.030_bb0145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage(\u2212)CD25(+)CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.030_bb0150","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J. Investig. Dermatol."},{"issue":"13","key":"10.1016\/j.intimp.2018.08.030_bb0155","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.08.030_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/985301","article-title":"Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis","volume":"2013","author":"Tang","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2018.08.030_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-15-19","article-title":"IL-33 is negatively associated with the BMI and confers a protective lipid\/metabolic profile in non-diabetic but not diabetic subjects","volume":"15","author":"Hasan","year":"2014","journal-title":"BMC Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2018.08.030_bb0175","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.20150894","article-title":"IL-33 amplifies an innate immune response in the degenerating retina","volume":"213","author":"Xi","year":"2016","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2018.08.030_bb0185","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0022034515577815","article-title":"IL-33 exacerbates periodontal disease through induction of RANKL","volume":"94","author":"Malcolm","year":"2015","journal-title":"J. Dent. Res."},{"issue":"11","key":"10.1016\/j.intimp.2018.08.030_bb0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2018.08.030_bb0195","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/eji.201444671","article-title":"IL-33 attenuates the development of experimental autoimmune uveitis","volume":"44","author":"Barbour","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2018.08.030_bb0200","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.28481","article-title":"Interleukin-33\/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells","volume":"134","author":"Jovanovic","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2018.08.030_bb0205","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta 1 maintains suppressor function and Foxp3 expression in CD4(+)CD25(+) regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2018.08.030_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161507","article-title":"IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGF beta release","volume":"11","author":"Siede","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2018.08.030_bb0215","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"issue":"34","key":"10.1016\/j.intimp.2018.08.030_bb0220","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.08.030_bb0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fimmu.2016.00193","article-title":"Breaking free of control: how conventional T cells overcome regulatory T cell suppression","volume":"7","author":"Mercadante","year":"2016","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.030_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20071477","article-title":"The AKT-mTOR axis regulates de novo differentiation of CD4(+)Foxp3(+) cells","volume":"205","author":"Haxhinasto","year":"2008","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.intimp.2018.08.030_bb0235","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.4049\/jimmunol.177.10.6598","article-title":"Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells","volume":"177","author":"Patton","year":"2006","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2018.08.030_bb0240","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","article-title":"T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.08.030_bb0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12865-015-0123-y","article-title":"Immunoexpression of TGF-beta\/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients","volume":"16","author":"Piotrowski","year":"2015","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.030_bb0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/imr.12148","article-title":"Signals and pathways controlling regulatory T cells","volume":"258","author":"Huynh","year":"2014","journal-title":"Immunol. Rev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918304600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918304600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T04:11:55Z","timestamp":1541131915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918304600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"alternative-id":["S1567576918304600"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.08.030","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}